Quality Improvement for STEMI Patients in China
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
Recruiting
Observational Study
ST Elevation Myocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200,000 (estimated)
- Sponsor
- China National Center for Cardiovascular Diseases · Government
Who this trial is looking for
This trial is looking for adults who have had a heart attack known as STEMI and arrived at the hospital within 48 hours of the symptoms starting. Participants will help evaluate and improve the care and treatment provided to patients with this condition.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with STEMI.
- I arrived at the hospital within 48 hours from when my symptoms started.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to investigate and evaluate clinical performance and quality measures for adults with acute ST-elevation myocardial infarction (STEMI) in China. Further more, the investigates like to develop quality improvement strategies and relevant tools focusing on treatment and clinical outcome in patients with STEMI. This is a annually survey , through consecutively recruiting all eligible i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with STEMI who arrive at the hospital within 48 hours from the symptoms onset.
Exclusion Criteria:
* None
Contacts